Madrigal Pharmaceuticals Inc (MDGL)

Free Cash Flow

-$168.65M

TTM · Period ending: · USD

MDGL logo

MDGL Free Cash Flow

Latest reported-$168.65M
MDGL TTM Free Cash Flow ($24.87M → -$168.65M)
High-resolution chart · PNG

MDGL free cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Madrigal Pharmaceuticals Inc Free Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFree Cash Flow (USD)
-168,650,000
-206,285,000
-272,413,000
-190,020,000
-161,631,000
-308,387,000
-401,411,000
-462,034,000
-438,322,000
-455,818,000
-391,121,000
-325,709,000
-303,284,000
-277,127,000
-259,211,000
-225,074,000
-214,694,000
-201,198,000
-190,618,000
-184,126,000
-190,919,000
-193,166,000
-170,548,000
-157,895,000
-115,354,000
-78,823,000
-66,097,000
-41,796,000
-35,653,000
-29,582,000
-23,403,000
-25,529,000
-25,076,000
-24,776,000
-27,189,000
-22,317,000
-21,778,637
-9,872,700
-9,169,700
-17,610,700
-31,684,063
-54,254,000
-64,941,000
-71,502,000
-71,421,000
-74,409,000
-77,551,000
-79,069,000
-78,567,000
-76,568,000
-75,983,000
-78,180,000
-72,015,000
-68,883,000
-61,729,000
-54,640,000
-52,901,000
-51,513,000
-50,542,000
-47,990,000
-45,361,000
-41,772,000
-38,595,000
-38,335,000
-37,301,000
-37,087,000
-51,697,000
-27,264,000
-4,256,000
-16,249,000
-12,164,000
-40,123,000
11,581,000
15,789,000
22,428,000
24,872,000
-54,337,000
-52,468,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.